HRTX — HERON THERAPEUTICS INC

Ownership history in CM Management, LLC  ·  21 quarters on record

This page tracks every 13F SEC filing in which CM Management, LLC reported a position in HERON THERAPEUTICS INC (HRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.33% (2025 Q1)
Avg. % of fund
0.74%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
21
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 750,000 — 0% 0.82% $975K $1.30
2025 Q3 ADDED 750,000 +150,000 +25.0% 0.79% $945K $1.26
2025 Q2 UNCHANGED 600,000 — 0% 1.13% $1.2M $2.07
2025 Q1 REDUCED 600,000 -100,000 -14.3% 1.33% $1.3M $2.20
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HRTX price (monthly, adj. close)

Other funds also holding HRTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 6.6% Tejara Capital Ltd 3Y 1.57% JW Asset Management, LLC 3Y 7Y 1.55% Congress Park Capital LLC 3Y 7Y 1.19% Stonepine Capital Management, LLC 3Y 7Y 1.17% Clearline Capital LP 3Y 7Y 0.78% Orchard Capital Management, LLC 3Y 0.77% Richmond Brothers, Inc. 3Y 0.47% Rubric Capital Management LP 3Y 7Y 0.47% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.4%
← Back to CM Management, LLC Holdings